Abstract
Glucagon-like peptide-1 (GLP-1) plays glucose homeostasis and delays gastric empty. Because GLP-1 activates GLP-1 receptor and this activation recruits insulin secretion in pancreatic β-cells. This biological action applied therapeutic treatment for type 2 diabetes mellitus using GLP-1 analogues, exendin-4 and lilaglutide. Although therapeutic approaches of GLP-1 analogues are very effective as a hypoglycemic agents, its side effects are occurred in clinical study such as pancreatitis, autoimmune hepatitis and acute kidney injury. To solve critical side effects in therapeutic treatment, alternative ways are still developed. In this review, we introduce the character of taste receptors and taste receptor signaling. Because taste receptors and taste receptor signaling are able to induce GLP-1 release from exogenous molecules in enteroendocrine L cells. And how we find and develop that safe exogenous molecules to induce GLP-1 are in natural resources against side effects. We suggest that mRNA variants of taste receptors and taste receptor signaling molecules are briefly screening to find GLP-1 secret-agogue in natural components including herbal medicines using biochip in enteroendocrine L cells.
Similar content being viewed by others
References
Leigh, J.P. & Du, J. Brief Report: Forecasting the Economic Burden of Autism in 2 015 and 2 025 in the United States. J. Autism. Dev. Disord. 45, 4135–4139 (2015).
Kim, K.S. & Jang, H.J. Medicinal Plants Qua Glucagon-Like Peptide-1 Secretagogue via Intestinal Nutrient Sensors. Evid. Based Complement. Alternat. Med. 2015, 171742 (2015).
Baggio, L.L. & Drucker, D.J. Biology of incretins: GLP-1 and GIP. Gastroenterology 132, 2131–2157 (2007).
Jang, H.J. et al. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc. Natl. Acad. Sci. USA 104, 15069–15074 (2007).
Drucker, D.J. et al. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc. Natl. Acad. Sci. USA 84, 3434–3438 (1987).
Schirra, J. et al. Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans. Gut 55, 243–251 (2006).
Alcantara, A.I. et al. Exendin-4 agonist and exendin(9-39)amide antagonist of the GLP-1(7-36)amide effects in liver and muscle. Arch. Biochem. Biophys. 341, 1–7 (1997).
Denker, P.S. & Dimarco, P.E. Exenatide (exendin-4)-induced pancreatitis: a case report. Diabetes Care 29, 471 (2006).
Kaakeh, Y., Kanjee, S., Boone, K. & Sutton, J. Liraglutide-induced acute kidney injury. Pharmacotherapy 32, e7–11 (2012).
Kern, E. et al. Liraglutide-induced autoimmune hepatitis. JAMA Intern. Med. 174, 984–987 (2014).
Bailey, C.J. & Day, C. Traditional plant medicines as treatments for diabetes. Diabetes Care 12, 553–564 (1989).
Kim, K.-H. et al. Aqueous extracts of Anemarrhena asphodeloides stimulate glucagon-like pepetide-1 secretion in enteroendocrine NCI-H 716 cells. BioChip J. 7, 188–193 (2013).
Kim, K.S., Egan, J.M. & Jang, H.J. Denatonium induces secretion of glucagon-like peptide-1 through activation of bitter taste receptor pathways. Diabetologia 57, 2117–2125 (2014).
Shin, M.H. et al. Hexane Fractions of Bupleurum falcatum L. Stimulates Glucagon-Like Peptide-1 Secretion through G beta gamma -Mediated Pathway. Evid. Based Complement. Alternat. Med. 2014, 1–8 (2014).
Shin, M.-H. et al. Gentiana scabra extracts stimulate glucagon-like peptide-1 secretion via G protein-coupled receptor pathway. BioChip J. 6, 114–119 (2012).
Suh, H.W. et al. A bitter herbal medicine Gentiana scabra root extract stimulates glucagon-like peptide-1 secretion and regulates blood glucose in db/db mouse. J. Ethnopharmacol. 172, 219–226 (2015).
Tan, M.J. et al. Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem. Biol. 15, 263–273 (2008).
Xie, J.T. et al. Ginseng berry reduces blood glucose and body weight in db/db mice. Phytomedicine 9, 254–258 (2002).
Choi, E.-K. et al. Hexane fraction of Citrus aurantium L. stimulates glucagon-like peptide-1 (GLP-1 )secretion via membrane depolarization in NCI-H 716 cells. BioChip J. 6, 41–47 (2012).
Kim, K.-S. et al. Transcriptomic analysis of the bitter taste receptor-mediated glucagon-like peptide-1 stimulation effect of quinine. BioChip J. 7, 386–392 (2013).
Adler, E. et al. A novel family of mammalian taste receptors. Cell 100, 693–702 (2000).
Kinnamon, S.C. Taste receptor signalling -from tongues to lungs. Acta Physiol. (Oxf). 204, 158–168 (2012).
Margolskee, R.F. The biochemistry and molecular biology of taste transduction. Curr. Opin. Neurobiol. 3, 526–531 (1993).
Margolskee, R.F. Molecular mechanisms of bitter and sweet taste transduction. J. Biol. Chem. 277, 1–4 (2002).
Vinolo, M.A., Hirabara, S.M. & Curi, R. G-proteincoupled receptors as fat sensors. Curr. Opin. Clin. Nutr. Metab. Care 15, 112–116 (2012).
Bayliss, W.M. & Starling, E.H. The mechanism of pancreatic secretion. J. Physiol. 28, 325–353 (1902).
Engelstoft, M.S. et al. A gut feeling for obesity: 7TM sensors on enteroendocrine cells. Cell Metab. 8, 447–449 (2008).
Berthoud, H.R. et al. Vagal sensors in the rat duodenal mucosa: distribution and structure as revealed by in vivo DiI-tracing. Anat. Embryol. (Berl). 191, 203–212 (1995).
Engelstoft, M.S. et al. Enteroendocrine cell types revisited. Curr. Opin. Pharmacol. 13, 912–921 (2013).
Field, B.C., Chaudhri, O.B. & Bloom, S.R. Bowels control brain: gut hormones and obesity. Nat. Rev. Endocrinol. 6, 444–453 (2010).
de Bruine, A.P. et al. Extracellular matrix components induce endocrine differentiation in vitro in NCI-H 716 cells. Am. J. Pathol. 142, 773–782 (1993).
Ong, W.K. et al. The role of the PDE4D cAMP phosphodiesterase in the regulation of glucagon-like peptide- 1 release. Br. J. Pharmacol. 157, 633–644 (2009).
Larsen, P.J. & Holst, J.J. Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter. Regul. Pept. 128, 97–107 (2005).
Dhaka, A., Viswanath, V. & Patapoutian, A. Trp ion channels and temperature sensation. Annu. Rev. Neurosci. 29, 135–161 (2006).
Chandrashekar, J. et al. T2Rs function as bitter taste receptors. Cell 100, 703–711 (2000).
Meyerhof, W. et al. The molecular receptive ranges of human TAS2R bitter taste receptors. Chem. Senses 35, 157–170 (2010).
Tahara, Y. et al. Development and Evaluation of a Miniaturized Taste Sensor Chip. Sensors (Basel, Switzerland) 11, 9878–9886 (2011).
Song, H.S. et al. Human taste receptor-functionalized field effect transistor as a human-like nanobioelectronic tongue. Nano Lett. 13, 172–178 (2013).
Song, H.S. et al. Bioelectronic tongue using heterodimeric human taste receptor for the discrimination of sweeteners with human-like performance. ACS Nano. 8, 9781–9789 (2014).
Ahn, S.R. et al. Duplex Bioelectronic Tongue for Sensing Umami and Sweet Tastes Based on Human Taste Receptor Nanovesicles. ACS Nano. 10, 7287–7296 (2016).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, KH., Jang, HJ. Development of GLP-1 secretagogue using microarray in enteroendocrine L cells. BioChip J 10, 272–276 (2016). https://doi.org/10.1007/s13206-016-0403-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13206-016-0403-5